US Treasury To Partner With Education Department To Collect Student Loan Debt

Lilly Slides After New Obesity Pill Prescription Data Disappoints Wall Street Shares of Eli Lilly & Co. fell in New York premarket trading after new industry prescription data for the drugmaker's blockbuster obesity shot Zepbound and recently approved oral weight-loss pill Foundayo disappointed Wall Street analysts. Foundayo generated 3,707 prescriptions in its second week, according to new prescription-tracking data from IQVIA cited by RBC Capital Markets analysts. That compares with 18,410 prescriptions for Novo's oral version of Wegovy during its second week after launch, suggesting Lilly's weight-loss drugs are falling behind...

Can You Price In No Longer Pricing Things In? By Michael Every of Rabobank At this point it isn’t a random walk but a determined march: markets have decided the Iran war and the Hormuz blockades are over, and everything is going to be better than normal imminently: the Nasdaq and S&P are at all-time highs and even worries over private credit are receding. In the real world, there are signs that back that stance and ones that say otherwise. Iran warned it could sink US ships in Hormuz if they police...

"I'm Not Racist": Musk Slams Snooty Leftist Interviewer, Says "I Support The Normal People" Authored by Steve Watson via Modernity News, During a terse exchange, Elon Musk told the virulently leftist editor-in-chief of The Economist that civil war in Britain is inevitable on current trends - driven by rapid migration of people whose beliefs clash with Western civilisation. In response, Zanny Minton Beddoes accused Musk of supporting the "far right," and amplifying racists. Musk called the coming confrontation a "reckoning," rejected the racist smear, and turned the tables on an interviewer determined...